An Integrated Model to Improve Medication Reconciliation in Oncology: Prospective Interventional Study
BackgroundAccurate medication reconciliation reduces the risk of drug incompatibilities and adverse events that can occur during transitions in care. Community pharmacies (CPs) are a crucial part of the health care system and could be involved in collecting essential informat...
Main Authors: | Alessandro Passardi, Patrizia Serra, Caterina Donati, Federica Fiori, Sabrina Prati, Roberto Vespignani, Gabriele Taglioni, Patrizia Farfaneti Ghetti, Giovanni Martinelli, Oriana Nanni, Mattia Altini, Giovanni Luca Frassineti, Martina Vittoria Minguzzi |
---|---|
Format: | Article |
Language: | English |
Published: |
JMIR Publications
2021-12-01
|
Series: | Journal of Medical Internet Research |
Online Access: | https://www.jmir.org/2021/12/e31321 |
Similar Items
-
Phase II study of gemcitabine, doxorubicin and paclitaxel (GAT) as first-line chemotherapy for metastatic breast cancer: a translational research experience
by: Maltoni Roberta, et al.
Published: (2006-03-01) -
Performance indicators for monitoring the integrated care pathway of patients with colorectal cancer: the E.Pic.A. project
by: Andrea Ricotti, et al.
Published: (2019-06-01) -
Randomized phase II study with two gemcitabine- and docetaxel-based combinations as first-line chemotherapy for metastatic non-small cell lung cancer
by: Zoli Wainer, et al.
Published: (2008-10-01) -
Effectiveness of bevacizumab in first- and second-line treatment for metastatic colorectal cancer: ITACa randomized trial
by: Elisabetta Petracci, et al.
Published: (2020-07-01) -
How has COVID-19 pandemic changed flu vaccination attitudes among an Italian cancer center healthcare workers?
by: Lucia Bertoni, et al.
Published: (2022-01-01)